Corvivo Cardiovascular, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
26
Ending by 2030
May 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 2 to 23, 2026 · next Dec 2
- 2 fees due Jan 21 to 28, 2027 · next Jan 21
- 1 fee due Feb 20, 2027The maintenance fee for Cardiovascular Prostheses (US 10,383,977) comes due Feb 20, 2027. Unpaid by Aug 20, 2027, it lapses early.
- 1 fee due Mar 1, 2027The maintenance fee for Compositions and Methods for Preventing Cardiac Arrhythmia (US 9,119,841) comes due Mar 1, 2027. Unpaid by Sep 1, 2027, it lapses early.
- 1 fee due Jun 24, 2027The maintenance fee for Cardiovascular Prostheses (US 10,512,710) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.
- 3 fees due Jul 5 to 26, 2027 · next Jul 5
- 1 fee due Aug 20, 2027The maintenance fee for Prosthetic Venous Valves (US 11,903,833) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
- 2 fees due Oct 12 to 30, 2027 · next Oct 12
Recent changes
- 1 term has ended since Aug 23, 2026
- Sep 3 US 10,864,233 Compositions and Methods for Treatment of Cardiovascular Disorders · term ended
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,149,496 | ECM Constructs for Treating Damaged Biological Tissue In force · High confidence | In force | High confidence | |
| US 9,610,149 | Extracellular Matrix Constructs for Treating Damaged Biological Tissue In force · High confidence | In force | High confidence | |
| US 10,512,711 | Articles for Tissue Regeneration with Biodegradable Polymer In force · High confidence | In force | High confidence | |
| US 9,642,692 | Extracellular Matrix Constructs for Treating Damaged Biological Tissue In force · High confidence | In force | High confidence | |
| US D688,372 | Prosthetic Tissue Valve In force · High confidence | In force | High confidence | |
| US 9,700,654 | Extracellular Matrix (ECM) Structures for Tissue Regeneration In force · High confidence | In force | High confidence | |
| US D694,408 | Prosthetic Tissue Valve In force · High confidence | In force | High confidence | |
| US 8,409,275 | Prosthetic Tissue Valve In force · High confidence | In force | High confidence | |
| US 8,449,607 | Prosthetic Tissue Valve In force · High confidence | In force | High confidence | |
| US 8,608,796 | Prosthetic Tissue Valve In force · High confidence | In force | High confidence |
Also on record, not counted in the 77: 31 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.